← All Zynex INC filings

Zynex INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

ZYXI
Zynex INC
10-K/A: Zynex Amends 10-K, Reveals Tricare Payment Suspension and Internal Control Weaknesses Amidst Profit Decline
Zynex, Inc. filed an amended annual report detailing a temporary payment suspension from Tricare, a 10% staff reduction, and identified material weaknesses in internal controls, despite achieving revenue growth and its ninth consecutive profitable year.
ZYXI
Zynex INC
10-K: Zynex Reports 2024 Results: Revenue Up, Strategic Restructuring Underway
Zynex reports a 4% increase in revenue for 2024 while implementing a restructuring plan to address temporary payment suspensions.
ZYXI
Zynex INC
10-K: Zynex Inc. Reports 2023 Financial Results, Highlights Growth and Strategic Initiatives
Zynex Inc. reports a 17% increase in revenue and a 29% increase in operating cash flow for 2023, alongside strategic investments in sales and product development.